Amy Ronneberg
Board Member
Actuate Therapeutics, Inc. (ACTU)Equibles does not estimate personal net worth.
Get an email with a short summary when Actuate Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ACTU alertsAbout Amy Ronneberg
Amy Ronneberg is recorded as Board Member at Actuate Therapeutics, Inc. (ACTU). The newest filing on record that lists Amy Ronneberg as Board Member at Actuate Therapeutics, Inc. (ACTU) is dated April 6, 2026. Actuate Therapeutics, Inc. reported in an 8-K filed August 14, 2024 that Amy Ronneberg was appointed Director, effective May 20, 2024. Actuate Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actuate Therapeutics, Inc. includes Daniel M. Schmitt (CEO and Board Member), Paul Lytle (CFO), Andrew P. Mazar (COO) and 7 others.
“each of Jason Keyes, Roger Sawhney, and Amy Ronneberg were appointed to the Company's Board of Directors (the "Board") on May 20, 2024.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Actuate Therapeutics, Inc.
- Daniel M. Schmitt CEO, Board Member
- Paul Lytle CFO
- Andrew P. Mazar COO
- Aaron G.L. Fletcher Board Member
- Dr. Dan Zabrowski Board Member
- Dr. Roger Sawhney Board Member
- Jason Keyes Board Member
- Martin H. Huber, MD Board Member
- Roger Sawhney Board Member
- Todd Thomson Board Member